title: Association Between Insulin Resistance and Bone Structure in Nondiabetic Postmenopausal Women.
abstract: The clinical consequences of insulin resistance and hyperinsulinemia on bone remain largely unknown.
  
  
  
  The objective of the study was to evaluate the effect of insulin resistance on peripheral bone geometry, volumetric bone mineral density (vBMD), bone microarchitecture, and estimated bone strength.
  
  
  
  This cross-sectional study included 146 postmenopausal, nondiabetic Caucasian women (mean age 60.3 ± 2.7 y) who were participating in the Study of Women's Health Across the Nation.
  
  
  
  There were no interventions.
  
  
  
  High-resolution peripheral quantitative computed tomography was used to assess bone density and microstructure at the distal radius and tibia. Fasting insulin and glucose were measured and insulin resistance was estimated using homeostasis model assessment of insulin resistance (HOMA-IR), with higher values indicating greater insulin resistance.
  
  
  
  There was a negative association between HOMA-IR and bone size and a positive association between HOMA-IR and total vBMD, trabecular vBMD, trabecular thickness, and cortical thickness at the radius and tibia. These relationships remained, even after adjusting for body weight and other potential covariates (eg, time since menopause, cigarette smoking, physical activity, prior use of osteoporosis medications or glucocorticoids).
  
  
  
  In nondiabetic, postmenopausal women, insulin resistance was associated with smaller bone size, greater volumetric bone mineral density, and generally favorable bone microarchitecture at weight-bearing and nonweight-bearing skeletal sites. These associations were independent of body weight and other potential covariates, suggesting that hyperinsulinemia directly affects bone structure independent of obesity and may explain, in part, the higher trabecular bone density and favorable trabecular microarchitecture seen in individuals with type 2 diabetes mellitus.
authors.affiliation: Department of Endocrinology (V.V.S.), Odense University Hospital, Odense 5000 C, Denmark; Endocrine Unit (J.S.F., M.L.B., E.W.Y.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Center for Advanced Orthopedic Studies (M.L.B.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
authors.forename: Vikram V
authors.initials: VV
authors.lastname: Shanbhogue
authors.affiliation: Department of Endocrinology (V.V.S.), Odense University Hospital, Odense 5000 C, Denmark; Endocrine Unit (J.S.F., M.L.B., E.W.Y.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Center for Advanced Orthopedic Studies (M.L.B.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
authors.forename: Joel S
authors.initials: JS
authors.lastname: Finkelstein
authors.affiliation: Department of Endocrinology (V.V.S.), Odense University Hospital, Odense 5000 C, Denmark; Endocrine Unit (J.S.F., M.L.B., E.W.Y.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Center for Advanced Orthopedic Studies (M.L.B.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
authors.forename: Mary L
authors.initials: ML
authors.lastname: Bouxsein
authors.affiliation: Department of Endocrinology (V.V.S.), Odense University Hospital, Odense 5000 C, Denmark; Endocrine Unit (J.S.F., M.L.B., E.W.Y.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Center for Advanced Orthopedic Studies (M.L.B.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
authors.forename: Elaine W
authors.initials: EW
authors.lastname: Yu
mesh_terms: D015502:Absorptiometry, Photon; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000453:epidemiology* / Q000378:metabolism*; D017698:Postmenopause / Q000378:metabolism*; D014057:Tomography, X-Ray Computed